PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer have?
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer has 847 citations in the OpenAlex counts ScholarIQ stores.
When was PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer published?
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer has 2016 year in the ScholarIQ index.
What is the open-access status of PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer?
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer has bronze oa status in the ScholarIQ index.
What is the DOI of PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer?
The DOI for PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer is on the source record.
What is the PMID of PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer?
The PMID for PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer is on the source record.
What is the OpenAlex record for PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer?
The OpenAlex for PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer is on the source record.